Document:

Form of Performance Share Award Agreement

 Exhibit 10.3 
 ROBBINS & MYERS, INC. 
 AWARD AGREEMENT 

PERFORMANCE SHARE AWARD TO
                                        

 This AWARD AGREEMENT (the “Agreement”) is entered into as of the Award Date set forth below between
ROBBINS & MYERS, INC., an Ohio corporation (the “Company”), and
                                        
(“Executive”). 
 A. The Company has established a 2012 Long-Term Incentive Plan (the “2012
LTIP”) as a sub-plan under its 2004 Stock Incentive Plan As Amended (the “2004 Plan”), copies of the 2012 LTIP and 2004 Plan have been delivered to Executive and are incorporated herein by this reference; 

B. For the purpose of encouraging Executive to have a proprietary interest in the Company through stock ownership, to continue in the
service of the Company and its Subsidiaries, and to render superior performance during the period from September 1, 2011 through August 31, 2014 (the “Performance Period”), the Compensation Committee (the
“Committee”) of the Board of Directors (the “Board”) of the Company has determined that Performance Shares should be awarded under the 2012 LTIP to Executive; and 

C. Any capitalized term used herein that is not defined herein shall have the meaning ascribed to it in the 2004 Plan. 

NOW, THEREFORE, THE COMPANY AND EXECUTIVE INTENDING TO BE LEGALLY BOUND HEREBY AGREE AS FOLLOWS: 

SECTION 1. PERFORMANCE SHARE AWARD. 
 1.1 Grant of Performance Shares 
 (a) The Company hereby grants to Executive on
October     , 2011 (the “Award Date”), subject to the terms and conditions of the 2012 LTIP, the 2004 Plan and this Agreement,
                                        
(            ) Performance Shares (the “Performance Shares”) as a Performance Share Award under the 2004 Plan. Each Performance Share represents the right to receive
one Common Share on August 31, 2014 if the performance goals established pursuant to the 2012 LTIP (the “Performance Goals”) for the Company’s fiscal years ending August 31, 2012 (“Fiscal
2012”), August 31, 2013 (“Fiscal 2013”), and August 31, 2014 (“Fiscal 2014”) are satisfied, provided Executive is continuously employed by the Company through August 31, 2014 (the
“Vesting Date”). Each of Fiscal 2012, Fiscal 2013 and Fiscal 2014 is referred to herein as a “Performance Year”, and one-third of the Performance Shares shall be allocated to each of the Performance Years. The
number of Performance Shares actually delivered to Executive on the Vesting Date is subject to adjustment based on Fiscal 2012, Fiscal 2013 and Fiscal 2014 results as more fully set forth in the 2012 LTIP. 

 (b) For each Performance Share earned and vested, Executive will be awarded dividend equivalents on the
Vesting Date (or such other date as the Performance Shares are paid pursuant to Section 1.4), with the dividends being calculated as if Executive had owned the shares from the Award Date through the Vesting Date (or such other date as the
Performance Shares are paid pursuant to Section 1.4). The aggregate amount of dividend equivalents will be divided by the average closing price of the Common Shares in August 2014 (or such other month ending immediately prior to the month in
which the Performance Shares are paid pursuant to Section 1.4) to arrive at the number of additional Common Shares Executive will receive. 

(c) If there shall occur any recapitalization, reclassification, stock dividend, stock split, reverse stock split, or other distribution with respect to
the Common Shares, or any merger, reorganization, consolidation or other change in corporate structure affecting the Common Shares, the Committee may, consistent with the terms of the 2004 Plan, cause an adjustment to be made in (i) the number
and kind of Common Shares subject to the then outstanding Performance Shares, (ii) the Performance Goals applicable to the Performance Shares, and (iii) any other terms of the Performance Share Award that are affected by the event.

 (d) Except as otherwise provided in Section 1.4, within two and one-half months following the Vesting Date, and upon the satisfaction of
all other applicable conditions with respect to the Performance Share Award, the Company shall deliver or cause to be delivered to Executive the Common Shares that have been earned through achievement of the Performance Goals and that have become
vesting in accordance with Section 1.1(a). 
 1.2 Restrictions 
 (a) Performance Shares may not be sold, transferred, assigned or subject any encumbrance, pledge, or charge or disposed of for any reason. 
 (b) Except as otherwise provided in Section 1.4, any Performance Shares for which the applicable Performance Goals have not been met shall be cancelled and shall be of no further force and effect.
Except as otherwise provided in Section 1.4, any Performance Shares earned based on the achievement of Performance Goals for a Performance Year shall be cancelled and shall be of no further force and effect if Executive fails to satisfy the
continuous employment requirement of Section 1.1(a). 
 (c) Any attempt to dispose of Performance Shares or any interest in such shares in
a manner contrary to the 2004 Plan or this Agreement shall be void and of no effect. 
 1.3 Performance Goals 

Subject to the provisions contained in Section 1.4, the Performance Goals for each Performance Year awarded herein shall be established as set forth
in the 2012 LTIP. 

  
 2 

 1.4 Acceleration on Change of Control; Termination of Employment and Forfeiture 

(a) Change of Control During the Performance Period. In the event of a Change of Control of the Company during the Performance Period, provided
that the Executive remains continuously employed by the Company until such Change of Control, all Performance Shares shall automatically become fully earned and vested on the date when the Change of Control is deemed to have occurred at the target
number of Performance Shares determined in accordance with the 2012 LTIP. The date of such Change of Control shall be the payment date for Performance Shares that vest on such date. 
 (b) In the event of the termination of Executive’s employment prior to the Vesting Date (and a Change of Control has not occurred at the time of termination of Executive’s employment), the
Performance Shares shall be forfeited unless the reason for Executive’s termination of employment was Disability, death, or Retirement, in which case the Performance Shares shall vest as follows: 

(i) Retirement During Performance Period. In the event of Executive’s termination of employment on account of Retirement
during the Performance Period, Executive shall vest in a number of Performance Shares equal to the sum of (i) the actual number of Performance Shares (if any) earned in accordance with the 2012 LTIP based on actual performance of the Company
during any Performance Year(s) ended prior to Executive’s Retirement, which Performance Shares shall be paid to Executive within seventy (70) days after Retirement, plus (ii) the product of (A) the actual number of Performance
Shares (if any) earned in accordance with the 2012 LTIP for the Performance Year in which Executive’s Retirement occurs based on the actual performance of the Company during such Performance Year, multiplied by (B) a fraction, the
numerator of which is the number of full and partial months of employment that the Executive completed during the Performance Year in which Executive’s Retirement occurs, and the denominator of which is 12 months (and rounded down to the next
whole number), which Performance Shares shall be paid to Executive within two and one-half months following the end of the Performance Year in which Executive’s Retirement occurs. 

(ii) Disability or Death During the Performance Period. In the event of Executive’s termination of employment during the
Performance Period on account of Disability or death, all Performance Shares shall automatically become fully earned and vested on the date of termination due to Disability or death at the target number of Performance Shares determined in accordance
with the 2012 LTIP. Such Performance Shares shall be paid to Executive or his beneficiary, as the case may be, within thirty (30) days following termination. 
 1.5 Section 162(m) Award 
 The Performance Share Award made herein is intended
to be a Section 162(m) Award as defined in the 2004 Plan and the provisions of the 2004 Plan applicable to such awards shall control the interpretation and performance of this Agreement. 

  
 3 

 1.6 Payment of Applicable Taxes 
 No Common Shares shall be delivered to Executive hereunder until any taxes payable by Executive with respect to the Common Shares have been withheld by the Company or paid by Executive. Executive may use
Common Shares to pay the Company all or any part of the mandatory federal, state or local withholding tax payments. Payment of applicable taxes may be made as follows: (i) in cash, (ii) payment in Common Shares owned by Executive,
including those that have been earned under the Plan, or (iii) by a combination of the methods described above. 
 SECTION 2.
REPRESENTATIONS OF EXECUTIVE. 
 Executive hereby represents to the Company that Executive has read and understands the provisions
of this Agreement, the 2012 LTIP and the 2004 Plan, and Executive acknowledges that Executive is relying solely on his or her own advisors with respect to the tax consequences of this Performance Share Award. 

SECTION 3. NOTICES. 
 All notices
or communications under this Agreement shall be in writing, addressed as follows: 
  

			
	To the Company:	  	Robbins & Myers, Inc.
		  	51 Plum Street, Suite 260
		  	Dayton, Ohio 45440
		  	Attention: Vice President, Human Resources
		
	To Executive:	  	At the last residence address of Executive on file with the Company.

 Any such notice or communication shall be (a) delivered by hand (with written confirmation of receipt) or sent by a
nationally recognized overnight delivery service (receipt requested), (b) be sent certified or registered mail, return receipt requested, postage prepaid, addressed as above (or to such other address as such party may designate in writing from
time to time), or (c) be given electronically, if receipt is confirmed electronically to the sender within 24 hours and the actual date of receipt shall determine the time at which notice was given. 

SECTION 4. PLAN CONTROLLING; CLAWBACK POLICY. 
 The Award is subject all of the terms conditions of the 2004 Plan. In the event of a conflict between the 2004 Plan and the 2012 LTIP or this Agreement, the provisions of the 2004 Plan shall control. The
Robbins & Myers, Inc. Compensation Clawback Policy dated October 5, 2010 is hereby incorporated by reference. 
 SECTION 5.
GOVERNING LAW.  
 This Agreement and its validity, interpretation, performance and enforcement shall be governed by the laws of
the State of Ohio other than the conflict of laws provisions of such laws. 

  
 4 

 SECTION 6. SECTION 409A OF THE CODE. 
 It is intended that the payments and benefits provided to Executive (who will not be eligible for Retirement, absent Committee consent, prior to the Vesting Date) under this Agreement shall be exempt from
the application of Section 409A of the Code pursuant to the “short-term deferral” exception of Treasury Regulation § 1.409A-1(b)(4). This Agreement shall be construed, administered, and governed in a manner that effects such
intent. 
 SECTION 7. SEVERABILITY. 
 Whenever possible, each provision in this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement shall be held to be
prohibited by or invalid under applicable law, then (a) such provision shall be deemed amended to accomplish the objectives of the provision as originally written to the fullest extent permitted by law and (b) all other provisions of this
Agreement shall remain in full force and effect. 
 SECTION 8. STRICT CONSTRUCTION. 

No rule of strict construction shall be implied against the Company, the Committee or any other person in the interpretation of any of the terms of the
Plan, this Agreement or any rule or procedure established by the Committee. 
 SECTION 9. DEFINITIONS. 

(a) “Change of Control” means and shall be deemed to have occurred on (i) the date upon which the Company is provided a copy
of a Schedule 13D, filed pursuant to Section 13(d) of the Securities Exchange Act of 1934 indicating that a group or person, as defined in Rule 13d-3 under said Act, has become the beneficial owner of 20% or more of the outstanding Voting
Shares or the date upon which the Company first learns that a person or group has become the beneficial owner of 20% or more of the outstanding Voting Shares if a Schedule 13D is not filed; (ii) the date of a change in the composition of the
Board such that individuals who were members of the Board on the date two years prior to such change (or who were subsequently elected to fill a vacancy in the Board, or were subsequently nominated for election by the Company’s shareholders, by
the affirmative vote of at least two-thirds of the directors then still in office who were directors at the beginning of such two year period) no longer constitute a majority of the Board; (iii) the date of the consummation of a merger or
consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the Voting Shares of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by
being converted into Voting Shares of the surviving entity) at least 50% of the total voting power represented by the Voting Shares of the Company or such surviving entity outstanding immediately after such merger or consolidation; or (iv) the
date shareholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all the Company’s assets. 

  
 5 

 (b) “Company” means Robbins & Myers, Inc., an Ohio corporation, and when
used with reference to employment of Executive, Company includes any Subsidiary of the Company. 
 (c) “Retirement”
means the Executive’s Early Retirement or Normal Retirement as defined in the 2004 Plan. 
 IN WITNESS WHEREOF, the Company and Executive
have duly executed this Agreement as of the Award Date. 
  

			
	ROBBINS & MYERS, INC.
		
	By:	 	  

			
	Name:	 	 Peter C. Wallace, President and Chief
 Executive Officer

	
	EXECUTIVE
	
	  

	Name:

  
 6Form of Warrant to Purchase Shares of Common Stock

 Exhibit 4.1 
 THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR
OTHER DISPOSITION OF THE WARRANT REPRESENTED BY THIS CERTIFICATE OR THE UNDERLYING SECURITIES MAY BE MADE EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, AND THE RULES AND REGULATIONS IN EFFECT THEREUNDER AND ALL
APPLICABLE STATE SECURITIES OR “BLUE SKY” LAWS (SUCH FEDERAL AND STATE LAWS, THE “SECURITIES LAWS”) OR (B) IF THE CORPORATION HAS BEEN FURNISHED WITH AN OPINION OF COUNSEL FOR THE HOLDER, WHICH OPINION AND COUNSEL
SHALL BE REASONABLY SATISFACTORY TO THE CORPORATION, TO THE EFFECT THAT SUCH TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION IS EXEMPT FROM THE PROVISIONS OF THE SECURITIES LAWS. 

PUMA BIOTECHNOLOGY, INC. 
 WARRANT TO PURCHASE SHARES OF COMMON STOCK 
  

			
	No. CS-A[__]	  	Dated: October 4, 2011

 THIS CERTIFIES THAT, for value
received, [INVESTOR], with its principal address at [            ], or its assigns (the “Holder”), is entitled to subscribe for and
purchase from PUMA BIOTECHNOLOGY, INC., a Delaware corporation (the “Company”), the Warrant Shares (as defined below) at a price per share equal to the Exercise Price, on
the terms and subject to the conditions contained herein only if a Triggering Event occurs. This warrant (this “Warrant”) is one of a series of warrants of like tenor originally issued by the Company pursuant to that certain
Securities Purchase Agreement, dated October 4, 2011, by and among the Company and the persons listed on Schedule I attached thereto (the “Purchase Agreement”). 

1. DEFINITIONS. The following terms, as used herein, have the following meanings:

 “Acquisition” means any sale, assignment, transfer or other disposition of all or substantially all
of the assets of the Company, or any reorganization, consolidation, merger, or sale of outstanding equity securities of the Company by the holders thereof, where the holders of the Company’s outstanding voting equity securities as of
immediately before such transaction beneficially own less than a majority of the outstanding voting equity securities of the surviving or successor entity as of immediately after such transaction. 

“Common Stock” means the common stock, par value $0.0001 per share, of the Company. 

“Convertible Securities” shall mean any bonds, debentures, notes or other evidences of indebtedness, and any
warrants, shares or any other securities convertible into, exercisable for, or exchangeable for Common Stock. 

  
 1 

 “Exercise Price” means $0.01 per share of Common Stock, as adjusted
for any subsequent stock splits, combinations, reorganizations or similar transactions. 
 “Expiration
Date” means the earlier of (a) the date which is 10 business days after the date on which the Holder receives written notice from the Company pursuant to Section 2.5 below of the occurrence of a Listing Event that has not been
preceded by a Triggering Event, and (b) the 5:00 p.m. Pacific Daylight Savings Time, October 4, 2021. 

“Listing Event” a Listing Event shall be deemed to have occurred upon the later to occur of (i) the date
that the Company’s Common Stock is first listed for quotation on any over-the-counter market (including, without limitation, the OTCBB, OTCQX or the Pink Sheets) or listed for quotation on any national securities exchange or trading system, and
(ii) the closing of the PIPE (as defined in the Purchase Agreement). 
 “Trading Day” means a day
on which the Company’s Common Stock is traded on any over-the-counter market (including, without limitation, the OTCBB, OTCQX or the Pink Sheets) or listed for quotation on any national securities exchange or trading system. 

“Triggering Event” a Triggering Event shall be deemed to have occurred if, after the date of this Warrant, but on
or prior to the date of a Listing Event, the Company shall (i) issue or sell any shares of Common Stock for a consideration per share (the “Sale Price”) less than $3.75 (as adjusted for any subsequent stock splits,
combinations, reorganizations or similar transactions), or (ii) issue or sell Convertible Securities with a per share conversion, exercise or exchange price (“Conversion Price”) less than $3.75 (as adjusted for any
subsequent stock splits, combinations, reorganizations or similar transactions). For purposes of determining the occurrence of a Triggering Event, none of the following issuances shall be considered the issuance or sale of Common Stock or
Convertible Security: 
  

	 	•	 	 The issuance of Common Stock upon the conversion of any then-outstanding Convertible Securities; provided, however, that this exception shall
not apply to the issuance or sale of the Convertible Securities themselves, as provided in clause (ii) above. 

  

	 	•	 	 The issuance of any Common Stock or Convertible Securities as a dividend on the Company’s stock; 

 

	 	•	 	 The issuance of up to 3,529,412 (as adjusted for any subsequent stock splits, combinations, reorganizations or similar transactions ) shares of Common
Stock (or options to purchase shares of Common Stock) to employees, directors or consultants of the Company under the Company’s 2011 Incentive Award Plan; and 

 

	 	•	 	 The issuance of shares of Common Stock or Convertible Securities to lenders, financial institutions, equipment lessors, or real estate lessors to the
Company in connection with a bona fide borrowing or leasing transaction (and expressly excluding any equity financing transactions) approved by the Company’s Board of Directors. 

  
 2 

 “Warrant Shares” shall mean the number of shares of Common Stock
calculated as the difference between (y) the number of shares of Common Stock calculated by dividing (1) [$insert aggregate purchase price] by (2) the lowest Sale Price or Conversion Price associated with any Triggering Event
occurring after the date hereof and prior to the Listing Event (and rounding down to the nearest whole share), and (z) [number of shares purchased in offering] (as adjusted for any subsequent stock splits, combinations, reorganizations or
similar transactions). 
 2. EXERCISE AND DURATION. 

2.1 The Holder may exercise this Warrant in whole and not in part, on any business day, for all of the Warrant Shares
purchasable hereunder, from and after the first business day following a Triggering Event to and including the Expiration Date. Upon the occurrence of any Triggering Event, the Company will promptly notify Holder at the address set forth in the
Company’s records that such Triggering Event has occurred. 
 2.2 This Warrant shall be exercisable
only by (i) the delivery to the Company at its address listed on the signature page (or at such other address as it may designate by notice in writing to the Holder) of this Warrant together with an executed Notice of Exercise in the form
attached hereto, and (ii) payment of the Exercise Price in one of the following manners: 
 (a)
Cash Exercise. The Holder may deliver immediately available funds (either in cash or by check), or by cancellation of indebtedness. 
 (b) Cashless Exercise. If an Exercise Notice is delivered at a time when a registration statement permitting the Holder to resell the Warrant Shares is not then effective or the prospectus
forming a part thereof is not then available to the Holder for the resale of the Warrant Shares, then the Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the
Holder the number of Warrant Shares determined as follows: 
 X = Y [(A-B)/A] 

where: 
 X = the
number of Warrant Shares to be issued to the Holder. 
 Y = the number of Warrant Shares with respect to which this Warrant is
being exercised. 
 A = the average of the closing prices for the five Trading Days immediately prior to (but not including) the
exercise date; provided, however, that if there is no public market for the Company’s Common Stock on the exercise date, then the value of “A” shall be equal to the then fair market value of a share of Company Common
Stock as determined in good faith by the Company’s Board of Directors. 
 B = the Exercise Price. 

  
 3 

 For purposes of Rule 144 promulgated under the Act, it is intended, understood and
acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was
originally issued. 
 2.3 Upon the exercise of the rights represented by this Warrant, a certificate or
certificates for the Common Stock so purchased, registered in the name of the Holder (or nominee of the Holder) or persons affiliated with the Holder, if the Holder so designates, shall be issued and delivered to the Holder within a reasonable time
after the rights represented by this Warrant shall have been so exercised. 
 2.4 The person in whose name
any certificate or certificates for shares of Common Stock are to be issued upon exercise of this Warrant shall be deemed to have become the holder of record of such shares on the date on which this Warrant was surrendered and payment of the
Exercise Price was made, irrespective of the date of delivery of such certificate or certificates, except that, if the date of such surrender and payment is a date when the stock transfer books of the Company are closed, such person shall be deemed
to have become the holder of such shares at the close of business on the next succeeding date on which the stock transfer books are open. 
 2.5 No later than two business days after the occurrence of a Listing Event, the Company shall deliver to the Holder written notice of the occurrence of such Listing Event. 

3. COVENANTS OF THE COMPANY. 

3.1 Covenants as to Common Stock. The Company covenants and agrees that all Common Stock that may be issued upon
the exercise of the rights represented by this Warrant, will, upon issuance, be validly issued and outstanding, fully paid and nonassessable, and free from all taxes, liens and charges with respect to the issuance thereof. The Company further
covenants and agrees that the Company will at all times, until the rights under this Warrant are no longer exercisable, have authorized and reserved, free from preemptive rights, a sufficient number of shares of Common Stock to provide for the
exercise of the rights represented by this Warrant. If at any time during the period at which the rights under this Warrant are exercisable, the number of authorized but unissued shares of Common Stock shall not be sufficient to permit exercise of
this Warrant, the Company will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes.

 3.2 No Impairment. The Company will not, by amendment of its certificate of incorporation or through
any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by
the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of all such action as may be necessary or appropriate in order to protect the exercise rights of the Holder against
impairment. The Company will not increase the par value of the Common Stock in excess of the Exercise Price for the Warrant. 

  
 4 

 3.3 Acquisition. Upon the closing of any Acquisition, the surviving
or successor entity shall assume this Warrant and the obligations of the Company hereunder, and this Warrant shall, from and after such closing, be exercisable for the same class, number and kind of securities, cash and other property as would have
been paid for or in respect of shares of Common Stock in connection with such Acquisition, at an aggregate exercise price equal to the aggregate Exercise Price in effect as of immediately prior to such closing. 

4. NO STOCKHOLDER RIGHTS. This Warrant in and of itself
shall not entitle the Holder to any voting rights or other rights as a stockholder of the Company. 
 5.
TRANSFER OF WARRANT. Subject to applicable laws and the restriction on transfer set forth on the first page of this Warrant, this Warrant and all rights hereunder are
transferable, by the Holder in person or by duly authorized attorney, upon delivery of this Warrant and the form of assignment attached hereto to any transferee designated by Holder. The Warrant may be transferred only in whole, and not in part. The
transferee shall sign an investment letter in form and substance satisfactory to the Company. 
 6. LOST,
STOLEN, MUTILATED OR DESTROYED WARRANT. If this Warrant is lost, stolen, mutilated or destroyed, the Company may, on such terms as to
indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination and tenor as the Warrant so lost, stolen, mutilated or destroyed. Any such
new Warrant shall constitute an original contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time enforceable by anyone. 

7. AMENDMENT; TERMINATION. This Warrant may be terminated, and any term
of this Warrant may be amended or waived, with the written consent of the Company and the holder of the Warrant. If a Triggering Event shall not have occurred on or prior to the date of a Listing Event, this Warrant shall automatically terminate and
shall be of no further force and effect on the Expiration Date. 
 8. NOTICES,
ETC. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed
telex or facsimile if sent during normal business hours of the recipient, if not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or
(d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the Company at the address listed on the signature page
and to the Holder at the addresses set forth on the first page of this Warrant or at such other addresses as the Company or Holder may designate by ten (10) days advance written notice to the other parties hereto. 

9. ACCEPTANCE. Receipt of this Warrant by the Holder shall constitute acceptance of
and agreement to all of the terms and conditions contained herein. 
 10. GOVERNING
LAW. This Warrant and all rights, obligations and liabilities hereunder shall be governed by the laws of the State of New York. 
 [REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK] 

  
 5 

 IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its duly authorized officer on the date set forth on the face of this Warrant. 
  

			
	Puma Biotechnology, Inc.
		
	By:	 	 
	Name:	 	Alan H. Auerbach
	Title:	 	President and Chief Executive Officer
		
	Address:	 	10940 Wilshire Boulevard, Suite 600 Los Angeles, California 90024

 [Signature Page to Warrant] 

 NOTICE OF EXERCISE 
 TO: Puma Biotechnology, Inc. 
 (1)
 ̈ The undersigned hereby elects to purchase              shares of Common Stock of Puma Biotechnology, Inc. (the
“Company”) pursuant to the terms of the attached Warrant, and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any. 

       ̈ The undersigned hereby elects to purchase
             shares of the Common Stock of the Company pursuant to the terms of the cashless exercise provisions set forth in Section 2.2 of the attached Warrant, and shall
tender payment of all applicable transfer taxes, if any. 
 (2) Please issue a certificate or certificates representing
said shares of Common Stock in the name of the undersigned or in such other name as is specified below: 
  

 
 (Name)

  
  

 
  

(Address) 

(3) The undersigned represents that (i) the aforesaid shares of Common Stock are being acquired for the account of the
undersigned for investment and not with a view to, or for resale in connection with, the distribution thereof and that the undersigned has no present intention of distributing or reselling such shares; (ii) the undersigned is aware of the
Company’s business affairs and financial condition and has acquired sufficient information about the Company to reach an informed and knowledgeable decision regarding its investment in the Company; (iii) the undersigned is experienced in
making investments of this type and has such knowledge and background in financial and business matters that the undersigned is capable of evaluating the merits and risks of this investment and protecting the undersigned’s own interests;
(iv) the undersigned understands that the shares of Common Stock issuable upon exercise of this Warrant have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), by reason of a
specific exemption from the registration provisions of the Securities Act, which exemption depends upon, among other things, the bona fide nature of the investment intent as expressed herein, and, because such securities have not been registered
under the Securities Act, they must be held indefinitely unless subsequently registered under the Securities Act or an exemption from such registration is available; (v) the undersigned is aware that the aforesaid shares of Common Stock may not
be sold pursuant to Rule 144 adopted under the Securities Act unless certain conditions are met and until the undersigned has held the shares for the number of years prescribed by Rule 144, that among the conditions for use of the Rule is the
availability of current information to the public about the Company and the Company has not made such information available and has no present plans to do so; and (vi) the undersigned agrees not to make any disposition of all or any part of the
aforesaid shares of Common Stock unless and until there is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition is made in accordance with said registration

 
statement, or the undersigned has provided the Company with an opinion of counsel satisfactory to the Company, stating that such registration is not required. 

 

					
	  	 		 	  
	(Date)	 		 	(Signature)
	  	 	  	 	  
	  	 	  	 	   
	  	 	  	 	(Print name)

 ASSIGNMENT FORM 

(To assign the foregoing Warrant, execute this form 
 and supply required information. Do not use this form to purchase shares.) 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced
thereby are hereby assigned to 
  

					
	Name:	  	 
		  	(Please Print)
		
	Address:	  	 
		  	(Please Print)
		
	Dated:	  	__________
			
	 Holder’s

Signature:
	  	 	  	
			
	 Holder’s

Address:
	  	 	  	

 NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the
Warrant, without alteration or enlargement or any change whatever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}]]